Mylan N.V. announced the US launch of Rivastigmine Transdermal System, 4.6 mg/24 hrs, 9.5 mg/24 hrs and 13.3 mg/24 hrs, a generic version of Novartis’ Exelon...
Thermo Fisher Scientific, the world leader in serving science, announced it has signed an agreement with BenchSci to utilize its proprietary machine learning platform to mine...
BD (Becton, Dickinson and Company), a leading global medical technology company, today announced it has completed the acquisition of TVA Medical, Inc., a company that develops...
Companion Medical, a leader in the development of advanced technology to improve diabetes care, has received FDA clearance for the Android version of its InPen app,...
Bausch + Lomb, a leading global eye health company and wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. announced that the US Food and Drug Administration (FDA)...
PTC Therapeutics, Inc. announced the presentation of data from the Translarna (ataluren) Phase II Study 030 demonstrating that the safety and pharmacokinetic profile of Translarna in...
Healcerion launched the SONON 300L handheld ultrasound device to the US market today, following FDA approval of this innovative wireless device for primary care providers. It...
Contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs) must introduce novel technologies early in the cell line development and production processes to stay...
Pacemakers that do not use wires to connect the device to the heart are successfully reducing the number of short-term and mid-term complications patients’ experience, a...
BD (Becton, Dickinson and Company) announced that it will conduct a live webcast of its third fiscal quarter 2018 earnings conference call on Thursday, August 2,...
A new benchtop instrument from Thermo Fisher Scientific, the Phadia 200, enables new levels of flexibility and automation for laboratory testing facilities to aid in the...
Waters Corporation will webcast its Q2 2018 financial results conference call live on Tuesday, July 24 at 8:00 a.m. eastern time. To listen to the conference...
Hyundai Hope On Wheels 501c3 nonprofit organization, celebrates its 20th year funding pediatric cancer research and will present Dr Jeffrey Toretsky of Georgetown Lombardi Comprehensive Cancer...
Halozyme Therapeutics, Inc., a biotechnology company developing novel oncology and drug-delivery therapies, will webcast its Quarterly Update Conference Call for the second quarter 2018 on Tues., Aug....
Plymouth based Urotronic today has received license to begin treating urethral strictures with its innovative Optilume drug-coated balloon (DCB) in Canada. The development is expected to...
Copyright © 2024 Medical Buyer